While compounding may be sourced from a Food and Drug Administration (FDA)-approved drug or bulk drug substance of an active pharmaceutical ingredient, the final compounded product is not considered FDA-approved, as it does not undergo FDA review for safety, effectiveness, and manufacturing quality
Successful salvage brachytherapy after infusion of gold auroshell nanoshells for localized prostate cancer in a human patient
Luke Halpern reporting for Pharmacy Times: MJH Life Sciences To view or add a comment, sign in More Relevant Posts For pharmacists, the shift from injection pen to pill bottle is not just a product change
Intracellular hypoxia detection Hypoxyprobe-1 (Hypoxyprobe Inc, Burlington, USA) is a substituted 2-nitroimidazole compound known as pimonidazole
Brandt S, Ballhause TM, Bernhardt A, Becker A, Salaru D, Le-Deffge HM, et al
For many patients, branded supply is simply not reliable enough to sustain a protocol